A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Smoking Cessation
Interventions
BIOLOGICAL

NicVAX Vaccine

NicVAX vaccine given 6 times over 6 months

BIOLOGICAL

Placebo Vaccine

Placebo vaccine given 6 times over 6 months

Trial Locations (25)

Unknown

NicVAX Investigator, Encino

NicVAX Investigator, Los Alamitos

NicVAX Investigator, Denver

NicVAX Investigator, New Haven

NicVAX Investigator, Brooksville

NicVAX Investigator, Orlando

NicVAX Investigator, Pembroke Pines

NicVAX Investigator, Tampa

NicVAX Investigator, Indianapolis

NicVAX Investigator, Wichita

NicVAX Investigator, Metairie

NicVAX Investigator, Annapolis

NicVAX Investigator, Milford

NicVAX Investigator, East Lansing

NicVAX Investigator, Rochester

NicVAX Investigator, Jackson

NicVAX Investigator, Omaha

NicVAX Investigator, Buffalo

NicVAX Investigator, Cincinnati

NicVAX Investigator, Mt. Pleasant

NicVAX Investigator, Knoxville

NicVAX Investigator, Nashville

NicVAX Investigator, Houston

NicVAX Investigator, Salt Lake City

NicVAX Investigator, Charleston

Sponsors
All Listed Sponsors
lead

Nabi Biopharmaceuticals

INDUSTRY

NCT01102114 - A Second Study of NicVAX/Placebo as an Aid for Smoking Cessation | Biotech Hunter | Biotech Hunter